Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03342417
Title Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors ExcellaBio LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Hoffman Oncology Bronx New York 10469 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field